Andrew Feigin

Towards Standardizing Nomenclature in Huntington’s Disease Research

M. MacDonald, B. Leavitt, Emily C. Gantman, 2024, Journal of Huntington's disease.

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

J. Klempír, R. Schubert, F. Squitieri, 2024, The Lancet Neurology.

The Efficacy and Safety Results of Laquinimod as a Treatment for Huntington Disease (LEGATO-HD) (S16.007)

P. Piccini, J. Savola, Gail Rynkowski, 2019, Neurology.